Conditional Approval is a Regulatory decision that allows a product, such as a drug or medical device, to be marketed based on Preliminary evidence of Efficacy And Safety, while additional data is collected post-approval. This mechanism accelerates access to Potentially beneficial products in Urgent situations, balancing the need for Rapid availability with Ongoing Evaluation of Long-term Outcomes.